INFLAMAPLS

Inflamalps is a biopharmaceutical company established in Valais, Switzerland. Their mission is ‘’to discover and develop novel medicines to treat inflammation with a focus on chronic inflammatory diseases of the eye and of the skin” Their team comprises experienced pharmaceutical industry and biotechnology company managers with significant track record in drug development, management and financing. Their focus is on developing topical treatments for inflammation-mediated diseases in ophthalmology and dermatology.